Regulatory Affairs

End-to-end regulatory strategy and global submission support for successful drug approval

Comprehensive Regulatory Solutions

Our regulatory affairs team provides strategic guidance and hands-on support throughout the product lifecycle. From early development through post-market requirements, we ensure your regulatory pathway is optimized for success across global markets.

Regulatory Operations

  • Document management and publishing
  • Submission tracking and management
  • Agency correspondence management
  • eCTD compilation and submission

Regulatory Strategy

  • Global regulatory strategy development
  • Regulatory gap analysis and remediation
  • Regulatory intelligence and assessment
  • Agency meeting preparation and support

Comprehensive Coverage Across Development

CMC Strategy

  • • Drug substance development
  • • Drug product development
  • • Analytical methods
  • • Stability programs
  • • Manufacturing controls

Medical Devices

  • • 510(k) submissions
  • • PMA applications
  • • De Novo requests
  • • CE marking strategy
  • • Quality system compliance

Pre-clinical Development

  • • IND-enabling studies
  • • Toxicology strategy
  • • IMPD preparation
  • • Pharmacology packages
  • • Safety assessments

Clinical Development

  • • Protocol development
  • • Clinical study reports
  • • Safety reporting
  • • DSUR/PSUR preparation
  • • Investigator brochures

Global Submission Expertise

We provide comprehensive support for regulatory submissions across major global markets, ensuring your applications meet the specific requirements of each regulatory authority.

US FDA Submissions

  • • IND Applications
  • • NDA/BLA Submissions
  • • 505(b)(2) Applications
  • • ANDA Submissions
  • • Orphan Drug Designations
  • • Fast Track/Breakthrough Therapy

EU EMA Submissions

  • • CTA Applications
  • • MAA Submissions
  • • Centralized Procedures
  • • Decentralized Procedures
  • • Mutual Recognition
  • • Scientific Advice

GL Global Markets

  • • Health Canada Submissions
  • • PMDA (Japan) Applications
  • • TGA (Australia) Dossiers
  • • Swissmedic Applications
  • • MHRA (UK) Submissions
  • • Emerging Markets Strategy

Expert Regulatory Authoring

Our experienced medical writers and regulatory professionals create high-quality documentation that meets regulatory standards and accelerates approval timelines.

Clinical Documents

  • ✓ Clinical Study Protocols
  • ✓ Clinical Study Reports
  • ✓ Patient Narratives
  • ✓ Clinical Summaries
  • ✓ Benefit-Risk Assessments

Regulatory Documents

  • ✓ Module 2 Summaries
  • ✓ Briefing Documents
  • ✓ Response to Questions
  • ✓ Labeling Documents
  • ✓ Risk Management Plans

Why Choose Kalvion Sciences for Regulatory Affairs

Proven Track Record

Successfully supported 200+ regulatory submissions with high approval rates across multiple therapeutic areas

Global Expertise

Deep understanding of regulatory requirements across FDA, EMA, and 40+ other regulatory authorities worldwide

Accelerated Timelines

Efficient processes and experienced teams that consistently deliver high-quality submissions ahead of schedule

Navigate Your Regulatory Pathway with Confidence

Partner with our regulatory experts to ensure successful submissions and faster market access for your products.

Start Your Regulatory Journey